Tag: CX 2025
CX 2025: Largest analysis of atherectomy data points towards lower target-lesion...
In the largest systematic review and meta-analysis of atherectomy data to date, Thomas Zeller (Bad Krozingen, Germany) reported that the technique is effective in...
CX 2025: Carotid endarterectomy maintains its golden hue in ‘great debate’
The established ‘gold standard’ approach to carotid revascularisation remained enshrined as the go-to operation as far as the CX audience gathered in Theatre 3...
CX 2025: Managing blood pressure with medical therapy may play a...
Results from the Central blood pressure and variability evaluation in abdominal aortic aneurysm (AAA), or CAVE-ON, study, which sought to measure the impact of...
Holistic, patient-centred pathways set out to address “disconnect” in venous care
In response to an audience poll during Thursday morning’s venous and lymphatic programme, 72% of respondents either disagreed or strongly disagreed with the statement...
CX 2025: EVAR founding fathers invoke revolutionary past to predict path...
The next spring forward in aortic stent grafting will be rooted in a greater understanding of the biomechanical forces acting upon devices alongside continued...
CX 2025: Sirolimus implant fails to meet fistula maturation endpoint in...
Results of the ACCESS 2 study, evaluating arteriovenous fistula (AVF) outcomes following use of the Sirogen (Vascular Therapies) sirolimus-eluting collagen implant, have shown that...
CX 2025: Bioresorbable scaffold technology has ‘potential to be a new...
In Wednesday's peripheral arterial programme, which hosted several podium-first presentations, lower limb drug-eluting technologies took centre stage—signalling a potential shift in the treatment paradigm...
Founding fathers of EVAR mark 40 years of aortic stent graft...
The 40-year history of endovascular aneurysm repair (EVAR) of the aorta wends a circuitous route, from behind the Iron Curtain in Soviet Ukraine, to...
New data, case discussion and debates to address critical challenges in...
New data and hot topic debates form the centrepiece of today’s (Wednesday’s) vascular access and renal interventions sessions at CX 2025, running throughout the...
New “The Swollen Leg” competition to raise public awareness of DVT...
The Rouleaux Club—the UK’s national vascular trainee society—in association with the CX Symposium 2025 and BIBA Medical, has announced a new competition intended to...
CX 2025 meets “critical” vascular challenges with plethora of new data
More than 50 podium-first presentations headline the 47th Charing Cross (CX) International Symposium—opening today (Wednesday 23 April) at the ExCeL London—with the aim of...
No longer a ‘one-trick shop’: Venous becomes core pillar of CX...
Charting the development of the Charing Cross (CX) venous and lymphatic programme from a sidebar event to becoming an “integral part” of the meeting’s...
Awaited first-release data and debates set to address critical challenges in...
“These crucial results will help to shape next steps in research, including ongoing randomised controlled trials comparing bioresorbable scaffolds to angioplasty, and eventually, to...
Challenges of 21st century aortic education, innovation and evidence get top...
Critical challenges in open and endovascular treatment of aortic disease will be brought into focus when world leaders in cardiac, aortic, and vascular therapies...
